Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
Analytical and Bioanalytical Chemistry|October 31, 2007
Lead isotopic analysis of infant bone tissue dating from the Roman era via multicollector ICP-mass spectrometryDavid De Muynck, Christophe Cloquet, Elisabeth Smits, et al.
Pharmacoepidemiology and Drug Safety|September 28, 2017
Thrombotic risk minimization for Diane-35 and genericsIrene D Bezemer, Elisabeth Smits, Fernie J A Penning-van Beest, et al.
Journal of Paediatrics and Child Health|October 6, 2018
Increased risk of morbidities and health-care utilisation in children born following preterm labour compared with full-term labour: A population-based studyEline Houben, Elisabeth Smits, Jeanne M Pimenta, et al.
European Heart Journal. Quality of Care & Clinical Outcomes|April 17, 2025
Uptitration of statin therapy in women and men: a population-based cohort studyPauline Kiss, Alicia Uijl, Diederick E Grobbee, et al.
Drugs - Real World Outcomes|July 5, 2022
Increased Risk of Stroke Due to Non-adherence and Non-persistence with Direct Oral Anticoagulants (DOACs): Real-World Analyses Using a Nested Case-Control Study from The Netherlands, Italy and GermanyEmily Holthuis, Elisabeth Smits, George Spentzouris, et al.
Drugs - Real World Outcomes|February 1, 2023
Time Trends in Patient Characteristics of New Rivaroxaban Users with Atrial Fibrillation in Germany and the NetherlandsAnnemarie Voss, Elisabeth Smits, Karin M A Swart, et al.
Journal of Hypertension|February 6, 2026
Sex differences in the use of blood pressure lowering therapy and blood pressure controlPauline A J Kiss, Tessa C X Duk, Diederick E Grobbee, et al.
Plos One|March 7, 2024
Safety profile of rivaroxaban in first-time users treated for venous thromboembolism in four European countriesAna Ruigómez, Tania Schink, Annemarie Voss, et al.
Drugs - Real World Outcomes|January 7, 2022
Adherence and Persistence with Once-Daily vs Twice-Daily Direct Oral Anticoagulants Among Patients with Atrial Fibrillation: Real-World Analyses from the Netherlands, Italy and GermanyElisabeth Smits, Felicita Andreotti, Eline Houben, et al.
Expert Opinion on Drug Safety|February 16, 2023
Safety and effectiveness of rivaroxaban for prevention of stroke in patients with nonvalvular atrial fibrillation: analysis of routine clinical data from four countriesLuis Alberto García Rodríguez, Ana Ruigómez, Tania Schink, et al.
Pageof 3